A share price of SELLAS Life Sciences Group Inc [SLS] is currently trading at $1.14, up 0.88%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling.
From an analyst’s perspective:
SELLAS Life Sciences Group Inc [NASDAQ: SLS] stock has seen the most recent analyst activity on July 21, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $18. On April 02, 2018, H.C. Wainwright initiated with a Buy rating and assigned a price target of $11 on the stock. Maxim Group upgraded its rating to a Buy but stick to its price target of $13 on March 19, 2018.
SELLAS Life Sciences Group Inc experienced fluctuations in its stock price throughout the past year between $0.77 and $1.84. Currently, Wall Street analysts expect the stock to reach $2.8 within the next 12 months. SELLAS Life Sciences Group Inc [NASDAQ: SLS] shares were valued at $1.14 at the most recent close of the market. An investor can expect a potential return of 145.61% based on the average SLS price forecast.
Analyzing the SLS fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.59, Equity is -3.25 and Total Capital is -3.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1172 points at the first support level, and at 1.0944 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1556, and for the 2nd resistance point, it is at 1.1712.
Ratios To Look Out For
To put it in perspective, the Current Ratio for SELLAS Life Sciences Group Inc [NASDAQ:SLS] is 1.72. In addition, the Quick Ratio stands at 1.72 and the Cash Ratio stands at 1.46.
